..stratégiai partnerként, széleskörű gyógyszer-nagykereskedelmi szolgáltatásokkal állunk azon ügyfeleink rendelkezésére, akik új termékekkel szeretnének megjelenni a magyarországi piacon. Legyen szó piackutatásról vagy felmérésről, hatósági bejelentésről vagy törzskönyvezésről, a megfelelő logisztikai infrastruktúra megteremtéséről vagy a releváns értékesítési hálózat kiépítéséről, a PHARMAROAD megbízható partnere számos nemzetközi vállalatnak hazai termékforgalmazás területén…

Launching a new product on a local market is always a challenging task. The process itself is complex; it has comprehensive regulatory, quality systems related, logistic and commercial aspects. First, a well-established working relationship is needed with the national regulatory agency to handle all the appropriate administrative procedures (such as registration, notification or licensing) pertaining to the introduction of the product in the local market. Then, sales channels are required to be opened with pharmacies, public and private healthcare institutions, and other wholesalers. Also, companies new to the local market need a reliable logistics base where their products are processed, stored, picked and packed and delivered to the buyers according to all the regulatory requirements. Our company excels in providing all the above-mentioned services to wide array of international partners while acting as their exclusive distributor in Hungary.

ANIKA THERAPEUTICS is a US-headquartered international corporation specialized primarily in the manufacturing of medical devices. The viscosupplementation product line (ORTHOVISC, ORTHOVOSC-T, MONOVISC and CINGAL) of the company is being exclusively distributed in Hungary by PHARMAROAD KFT. since 2008. These hyaluronic acid based products are injected into the synovial fluid surrounding the joints to ease osteoarthritis pain, improve mobility and hence the quality of life for patients. From 2020, our company will also be in charge of distributing HYALOFAST in the Hungarian market. HYALOFAST is a non-woven 2×2 cm or 5×5 cm biodegradable hyaluronic acid-based scaffold for hyaline-like cartilage regeneration. It is used for the entrapment of mesenchymal stem cells (MSCs) to arthroscopically treat both chondral and osteochondral lesions in the knee and ankle.